2023 scientific publications roundup

2023 has been a record year for clients using the Nanolive system in their scientific publications. The number of peer-reviewed publications has continued to increase, and there has been a real growth in groups publishing pre-prints to give a preview of their work.

Immunology was one of the most popular applications, with scientists taking advantage of Nanolive’s label-free, high resolution imaging to study neutrophil extracellular traps, platelets, blood clots, and many types of different immune cells.

Nanolive was also chosen to study cellular metabolism; in particular to image lipid droplets and mitochondrial dynamics.

Clients Publications graph

This word cloud summarizes the key words most commonly featured in papers this year:

Word cloud

Some of this year’s publication highlights:

Closer to understanding coronavirus: Research results with Institut Pasteur: https://www.nanolive.com/closer-to-understanding-coronavirus-research-results-with-institut-pasteur/

Nanolive empowers groundbreaking ferroptosis research published in Nature: https://www.nanolive.com/nanolive-empowers-groundbreaking-ferroptosis-research-published-in-nature/

New possibilities for potent cancer immunotherapies: https://www.nanolive.com/new-possibilities-for-potent-cancer-immunotherapies-with-nanolive-solutions/

Confirming the success of a cosmetic treatment for melasma at mesoestetic: https://www.nanolive.com/nanolive-imaging-confirms-success-of-mesoestetics-new-treatment-at-the-subcellular-level/

Mitochondrial secretion captured by Nanolive’s live cell imaging in new Cell Metabolism Paper: https://www.nanolive.com/mitochondrial-secretion-captured-by-nanolives-live-cell-imaging-in-new-cell-metabolism-paper/

Studying synaptic proteins involved in plasticity and neuroprotection: https://www.nanolive.com/towards-a-therapy-to-reduce-damage-after-traumatic-brain-injury-with-nanolive-solutions/

 

A list of all client publications using Nanolive imaging is available here: https://www.nanolive.com/resources/publications/

Read our latest news

Label-free assessment of immunotherapies for liquid tumors

Label-free assessment of immunotherapies for liquid tumors

From activation to target engagement and killing, Nanolive’s revolutionary technology enables the identification of the most effective therapeutic candidates for liquid tumors using live, label-free and advanced automated analysis of effector cell activity and function. Discover the case study data.
Simplifying drug delivery assessment: Industry perspectives

Simplifying drug delivery assessment: Industry perspectives

Optimization of drug delivery systems can become slow, resource intensive, and reliant on incomplete information. With one assay, Nanolive monitors the complete dynamics of drug delivery, reducing phototoxicity from labels and helping teams identify where delivery succeeds or fails.

Subscribe to our newsletter